Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine
Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Maureen Rutten-van Mölken on behalf of the HEcoPerMed Consortium
in: PharmacoEconomics (2021)
The objective of this study was to develop guidance contributing to improved consistency and quality in economic evaluations of personalised medicine (PM), given current ambiguity about how to measure the value of PM as well as considerable variation in the methodology and reporting in economic evaluations of PM.
The paper is open access online, find it here: